Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$29.38 +0.89 (+3.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Amphastar Pharmaceuticals (AMPH) Return on Equity [ROE] (2014 - 2026)

Updated

Amphastar Pharmaceuticals' Return on Equity [ROE] came in at 10.19% for Q2 2026, down 7.67 percentage points from 17.86% a year earlier but up 0.05 percentage points from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Amphastar Pharmaceuticals' Return on Equity [ROE] was 12.90%, down 10.36 percentage points from FY2024.

  • Return on Equity [ROE] carries a five-year change of +12.65 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was 23.26% in FY2024 (-0.29 pp), 23.55% in FY2023 (+4.79 pp), 18.76% in FY2022 (+4.60 pp) and 14.16% in FY2021 (+13.91 pp).
  • The five-year range for quarterly Return on Equity [ROE] is 8.41% (Q3 2021) to 24.03% (Q2 2024).
  • Year-over-year, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -5.67 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2022 (a gain of 17.73 percentage points), and the weakest in Q4 2025 (a drop of 9.32 percentage points).
  • Business Quant data shows AMPH's Return on Equity [ROE] at 10.14% (Q1 2026), 12.53% (Q4 2025) and 14.55% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 19.33%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.63%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 21.60%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 72.13%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -31.17%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 4.66%
10 Amphastar Pharmaceuticals 1.25 Bn 156.30 Mn 99.63 Mn 12.51%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 12.51%
Jun 30, 2026 10.19%
Mar 31, 2026 10.14%
Dec 31, 2025 12.53%
Sep 30, 2025 14.55%
Jun 30, 2025 17.86%
Mar 31, 2025 19.09%
Dec 31, 2024 21.85%
Sep 30, 2024 21.89%
Jun 30, 2024 24.03%
Mar 31, 2024 23.58%
Dec 31, 2023 22.28%
Sep 30, 2023 22.85%
Jun 30, 2023 17.92%
Mar 31, 2023 17.30%
Dec 31, 2022 17.68%
Sep 30, 2022 15.38%
Jun 30, 2022 18.86%
Mar 31, 2022 18.07%
Dec 31, 2021 14.46%
API Access

Amphastar Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AMPH&period=max&api_key=YOUR_API_KEY